Cargando…

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach

Individuals with nonalcoholic fatty liver disease (NAFLD) have an altered gut microbiota composition. Moreover, hepatic DNA methylation may be altered in the state of NAFLD. Using a fecal microbiota transplantation (FMT) intervention, we aimed to investigate whether a change in gut microbiota compos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stols-Gonçalves, Daniela, Mak, Anne Linde, Madsen, Mette S., van der Vossen, Eduard W. J., Bruinstroop, Eveline, Henneman, Peter, Mol, Femke, Scheithauer, Torsten P. M., Smits, Loek, Witjes, Julia, Meijnikman, Abraham Stijn, Verheij, Joanne, Nieuwdorp, Max, Holleboom, Adriaan G., Levin, Evgeni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269428/ https://www.ncbi.nlm.nih.gov/pubmed/37317027 http://dx.doi.org/10.1080/19490976.2023.2223330

Ejemplares similares

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort
por: Troelstra, Marian A., et al.
Publicado: (2021)

Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2019)

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease
por: Troelstra, Marian A., et al.
Publicado: (2022)

Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2022)

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Houttu, Veera, et al.
Publicado: (2021)

Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis
por: Houttu, Veera, et al.
Publicado: (2022)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Restoring the autonomic balance to reduce liver steatosis
por: Bruinstroop, Eveline, et al.
Publicado: (2019)

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease
por: Van Dijk, Anne-Marieke, et al.
Publicado: (2021)

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Role of hepatic deiodinases in thyroid hormone homeostasis and liver metabolism, inflammation, and fibrosis
por: Bruinstroop, Eveline, et al.
Publicado: (2023)

Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Mak, Anne Linde, et al.
Publicado: (2021)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome
por: van der Vossen, Eduard W. J., et al.
Publicado: (2021)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
por: Meijnikman, Abraham S., et al.
Publicado: (2022)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Recent insights into the role of microbiome in the pathogenesis of obesity
por: van der Vossen, Eduard W. J., et al.
Publicado: (2022)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Metabolic-associated Fatty Liver Disease as Assessed by the Fatty Liver Index Among Migrant and Non-migrant Ghanaian Populations
por: van Dijk, Anne-Marieke, et al.
Publicado: (2021)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
por: van Son, Koen C., et al.
Publicado: (2023)

Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease
por: Del Barrio, María, et al.
Publicado: (2023)

Physical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort—The HELIUS Study
por: Houttu, Veera, et al.
Publicado: (2021)

Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study
por: Vali, Yasaman, et al.
Publicado: (2022)

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Does disease start in the mouth, the gut or both?
por: Prodan, Andrei, et al.
Publicado: (2019)

Thyroid Hormones and Thyromimetics: A New Approach to Nonalcoholic Steatohepatitis?
por: Sinha, Rohit A., et al.
Publicado: (2020)

Consensus report: faecal microbiota transfer – clinical applications and procedures
por: König, J., et al.
Publicado: (2016)

Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
por: Grobbee, Esmée J., et al.
Publicado: (2022)

Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis
por: Stadlbauer, Vanessa, et al.
Publicado: (2020)

Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects
por: Timmer, C., et al.
Publicado: (2021)

OR01-06 Resistance to Thyroid Hormone Beta Is Associated with an Increase in Hepatic Fat Measured by Transient Elastography (Fibroscan(®)) with Controlled Attenuation Parameter (CAP)
por: Chaves, Carolina Marques, et al.
Publicado: (2020)

Hypothyroidism: The difficulty in attributing symptoms to their underlying cause
por: Jansen, Heleen I., et al.
Publicado: (2023)

Differential DNA methylation in familial hypercholesterolemia
por: Reeskamp, Laurens F., et al.
Publicado: (2020)

A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey
por: Driessen, Stan, et al.
Publicado: (2023)

Free Faecal Water: Analysis of Horse Faecal Microbiota and the Impact of Faecal Microbial Transplantation on Symptom Severity
por: Laustsen, Louise, et al.
Publicado: (2021)

Fæcal Anæmia
por: Hehir,
Publicado: (1890)

Cannot write session to /tmp/vufind_sessions/sess_i4a0av7gl4iavunldo0rndk3oe